Baidu
map

Heart:房颤患者接受心脏手术同时行消融治疗安全有效

2014-03-26 cath 医学论坛网

澳大利亚和比利时学者对接受心脏手术治疗的心房颤动患者同时进行外科消融治疗与不进行外科消融的临床转归情况进行了随机对照研究(RCT)的荟萃分析,结果表明,患者在接受心脏手术的同时进行外科消融治疗在恢复其窦性心律的方面是安全且有效的。研究论文3月20日在线发表于《心脏》(Heart)。 研究者对6个数据库进行了电子检索,鉴别了所有对比了心房颤动患者接受心脏手术的同时进行外科消融和非消融相关的RCT研

澳大利亚和比利时学者对接受心脏手术治疗的心房颤动患者同时进行外科消融治疗与不进行外科消融的临床转归情况进行了随机对照研究(RCT)的荟萃分析,结果表明,患者在接受心脏手术的同时进行外科消融治疗在恢复其窦性心律的方面是安全且有效的。研究论文3月20日在线发表于《心脏》(Heart)。

研究者对6个数据库进行了电子检索,鉴别了所有对比了心房颤动患者接受心脏手术的同时进行外科消融和非消融相关的RCT研究。根据预先设定的临床终点提取和分析数据。

结果共纳入了16项RCT相关研究。在所有≥12 个月的随访研究中,外科消融组患者的窦性心律普遍明显较高(P<0.00001)。两组患者的死亡率[比值比(OR )1.05;P =0.83]、起搏器置入(OR 0.88;P=0.64)和神经病学事件(OR 0.86;P=0.74)均无显著差异。累积荟萃分析显示,随着时间进展这些趋势仍保持一致。

原始出处:

Phan K1, Xie A, La Meir M, Black D, Yan TD.Surgical ablation for treatment of atrial fibrillation in cardiac surgery: a cumulative meta-analysis of randomised controlled trials.Heart. 2014 Mar 20. doi: 10.1136/heartjnl-2013-305351. 


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1355841, encodeId=ed95135584117, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421588, encodeId=d75b142158891, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562220, encodeId=c6f01562220be, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597709, encodeId=a56a159e7097f, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614237, encodeId=57db161423eaf, content=<a href='/topic/show?id=64f95426122' target=_blank style='color:#2F92EE;'>#房颤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54261, encryptionId=64f95426122, topicName=房颤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937e19519012, createdName=hittouch, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=)]
    2014-03-28 zhaojie88
  2. [GetPortalCommentsPageByObjectIdResponse(id=1355841, encodeId=ed95135584117, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421588, encodeId=d75b142158891, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562220, encodeId=c6f01562220be, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597709, encodeId=a56a159e7097f, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614237, encodeId=57db161423eaf, content=<a href='/topic/show?id=64f95426122' target=_blank style='color:#2F92EE;'>#房颤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54261, encryptionId=64f95426122, topicName=房颤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937e19519012, createdName=hittouch, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1355841, encodeId=ed95135584117, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421588, encodeId=d75b142158891, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562220, encodeId=c6f01562220be, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597709, encodeId=a56a159e7097f, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614237, encodeId=57db161423eaf, content=<a href='/topic/show?id=64f95426122' target=_blank style='color:#2F92EE;'>#房颤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54261, encryptionId=64f95426122, topicName=房颤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937e19519012, createdName=hittouch, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1355841, encodeId=ed95135584117, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421588, encodeId=d75b142158891, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562220, encodeId=c6f01562220be, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597709, encodeId=a56a159e7097f, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614237, encodeId=57db161423eaf, content=<a href='/topic/show?id=64f95426122' target=_blank style='color:#2F92EE;'>#房颤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54261, encryptionId=64f95426122, topicName=房颤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937e19519012, createdName=hittouch, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1355841, encodeId=ed95135584117, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421588, encodeId=d75b142158891, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562220, encodeId=c6f01562220be, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597709, encodeId=a56a159e7097f, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614237, encodeId=57db161423eaf, content=<a href='/topic/show?id=64f95426122' target=_blank style='color:#2F92EE;'>#房颤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54261, encryptionId=64f95426122, topicName=房颤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937e19519012, createdName=hittouch, createdTime=Fri Mar 28 01:47:00 CST 2014, time=2014-03-28, status=1, ipAttribution=)]

相关资讯

Neurology:房颤影响脑卒中患者长期生存率

房颤是一种日益普遍的疾病,它通过增加缺血性卒中的风险而使致死致残率显著升高。卒中伴房颤的患者同不伴房颤的患者相比,神经缺陷更严重,短期30天的死亡率更高。但目前关于其对长期生存影响的研究很少。因此来自加利福尼亚大学医学系Margaret C. Fang博士等研究房颤对卒中长期生存率影响,结果在线发表在2014年2月14日的Neurology杂志上。 研究随访了13,5

Circulation:暂时中断利伐沙班和华法林均与不良转归相关

英国一项研究表明,在接受利伐沙班和华法林治疗的非瓣膜病房颤患者中,暂时中断(TI)口服抗凝药物治疗较为常见,并且均与实质性的卒中和出血风险具有相关性。论文2月19日在线发表于《循环》(Circulation)杂志。ROCKET AF试验在非瓣膜病房颤患者中对利伐沙班或华法林进行了研究,并记录了因任何原因出现TI(3~30天)患者的基线特征、治疗以及包括卒中、非中枢神经系统血栓栓塞、死亡、心肌梗死和

CIT 2014:心房颤动的卒中、出血及风险评分

心房颤动(房颤)是临床上最常见的心律失常之一。同正常人群相比,房颤具有很高的致死率和致残率,血栓栓塞并发症是其致残、致死的主要原因。非瓣膜性房颤患者的卒中风险是正常人的 5~6倍,年发生率约为5%。因此,预防卒中对房颤患者尤为重要。 口服抗凝药是目前预防房颤血栓栓塞并发症最有效的方法,调整剂量的华法林可使房颤卒中的相对危险降低68%,优于单用或双联抗血小板治疗。真实世界研究荟萃同时表明,华法林显

孙志军/吴永全:急性心力衰竭合并房颤发作如何处理?

1 急性心力衰竭与房颤 最近的文献将急性心力衰竭定义为心力衰竭的症状和体征急性发作和(或)加重的一组临床综合征。依据目前急性心力衰竭的定义,除传统的器质性心脏疾病原因导致的急性左心衰竭外,其他的一些临床急症也归类为急性心力衰竭,如慢性心力衰竭的急性发作或加重,非器质性心脏病导致的急性右心衰竭的发作或加重等。 房颤是临床实践中最常见的心律失常,大约占因心律失常住院

孙志军/吴永全:急性心力衰竭合并房颤发作如何处理?

1 急性心力衰竭与房颤 最近的文献将急性心力衰竭定义为心力衰竭的症状和体征急性发作和(或)加重的一组临床综合征。依据目前急性心力衰竭的定义,除传统的器质性心脏疾病原因导致的急性左心衰竭外,其他的一些临床急症也归类为急性心力衰竭,如慢性心力衰竭的急性发作或加重,非器质性心脏病导致的急性右心衰竭的发作或加重等。 房颤是临床实践中最常见的心律失常,大约占因心律失常住院患者的1/3.据统计

JAMA:华法林可改善伴房颤的急性心梗患者预后

瑞典一项研究表明,在伴有房颤的急性心梗患者中,华法林治疗与死亡、心梗和缺血性卒中复合转归风险降低具有相关性,并且未升高出血风险。论文3月5日在线发表于《美国医学会杂志》。 此项研究共纳入24317例血清肌酐水平已知且伴有房颤的急性心梗存活者,并且21.8%的受试者在出院时应用华法林。依据估计肾小球滤过率(eGFR)对慢性肾病分级加以归类。复合终点由死亡以及心梗或缺血性卒中再次住院组成。主要转归指

Baidu
map
Baidu
map
Baidu
map